Bristol-Myers introduced BLENOXANE (bleomycin sulfate) for squamous cell cancers, head and neck cancers, and non-Hodgkins lymphomas
In 1973, Bristol-Myers introduced several early medicines, beginning with BLENOXANE (bleomycin sulfate) for squamous cell cancers, head and neck cancers, and non-Hodgkins lymphomas.
Tags:
Source: Bristol-Myers Squibb Company
Credit:
